Track topics on Twitter Track topics that are important to you
KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.
Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious diseases without the deleterious side effects commonly experienced with today's drugs.
Karo Bio is a drug discovery company focusing its research on the discovery and pre-clinical phases of drug development. Research is conducted primarily in the area of nuclear receptors.
Nuclear receptors are proteins in the cell nucleus that act as receivers for a number of key hormones that enable the essential regulation of organs in the body. Through the understanding of nuclear receptors in drug design, new tissue selective drugs can be developed that have fewer or no side effects.
Through ongoing partnerships with outstanding academic and research institutions, such as the Karolinska Institute, home of the Nobel Prize, Karo Bio continues to be at the forefront of new discoveries to advance the Company's work with nuclear receptors and other research endeavors. With the current programs underway, Karo Bio is diligently working to discover and develop drugs for important therapeutic areas such as women's health, diabetes, inflammatory disease, obesity, cardiovascular disease, and atherosclerosis.
In addition to nuclear receptor research and development, Karo Bio also offers a novel approach to target validation and high-throughput screening with proprietary BioKey® technology. This proteomics-based drug discovery technology is ideal for the development of screens for targets of unknown function and for targets difficult to screen by traditional methods. The proprietary BioKey® technology is used for internal discovery programs and collaborative out-licensing agreements with pharmaceutical and biotechnology companies.
Novum 141 57
Phone: ++46 8 608 6074
Fax: ++46 774 8261
Nasdaq Stockholm AB har fattat beslut om att stoppa handeln för aktierna i Karo Pharma AB (KARO, ISIN-kod SE0007464888, orderbok ID 003927 från klockan 12:45 tills vidare med hänvisning till 22 kap...
Med hänvisning till pressmeddelandet som Karo Pharma AB publicerade i dag klockan 15:10 har Nasdaq Stockholm AB i samråd med Finansinspektionen beslutat att handeln i aktierna i Karo Pharma AB (KAR....
On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary Offer") to acquire all shares in Wei...
Karo Pharma AB ("Karo Pharma") has today successfully completed the voluntary offer for Weifa ASA ("Weifa"). Payment of the offer price is being made today to the Weifa shareholders who accepted t...
Karo Pharma AB ("Karo Pharma") has today successfully completed the voluntary offer for Weifa ASA ("Weifa"). Payment of the offer price is being made today to the Weifa shar...
Reference is made to the offer document dated 11 September 2017 regarding Karo Pharma AB's ("Karo Pharma") conditional voluntary offer (the "Voluntary Offer") to acquire all of the shares in Weifa...
Following final registration of acceptances, the final acceptance level in Karo Pharma AB's ("Karo Pharma") voluntary offer ("Voluntary Offer") to acquire all shares i...
Weifa ASA ("Weifa"; OSE: WEIFA) today announced that Karo Pharma AB (publ) ("Karo Pharma"), has commenced the voluntary cash offer (the "Offer") to acquire the entire issued share capital of Weifa...
Rangatahi Tū Rangatira (R2R) is a national health promotion programme in Aotearoa New Zealand which aims to promote cultural and physical wellbeing for rangatahi (young people) and their whānau (fam...
KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious...
Karo Bio is an innovative drug discovery and development company specializing in nuclear receptors for the development of novel pharmaceuticals. The company has a strong project portfolio primarily ta...
We have published hundreds of karo bio news stories on BioPortfolio along with dozens of karo bio Clinical Trials and PubMed Articles about karo bio for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of karo bio Companies in our database. You can also find out about relevant karo bio Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...